Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07020520 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures

Study acronym: ENDURE1
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 5 to 7v5
  2. Study sites: 2 to 5v4
  3. Start date changed from estimate of Sep 30, 2025 to Oct 1, 2025
    • Site contacts updated at 1 of 2 sites
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Primary completion date: Jan 31, 2027 to Feb 28, 2027
    • Study completion date: Jun 30, 2031 to Jul 30, 2031
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Urotronic Inc.
6 trials monitored
See 1 trial at risk
The main objective of this clinical investigation is to assess the safety and feasibility of the Optilume DCB for treatment of ureteric strictures.
Trial Details
NCT Number NCT07020520
Lead Sponsor Urotronic Inc.
Collaborators: Laborie Medical Technologies Inc.
Conditions
(from sponsor)		 Ureteral Stricture
Related terms Constriction, Pathologic
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov